Decades Later, Congress Continues Debating the Preserve Access to Affordable Generics (and Biosimilars) Act; But will the Recent Jarkesy SCOTUS Decision Finally Put an End to the Insanity?
FDA Law Blog
AUGUST 29, 2024
Rather, the bill is structured so that liability is fully determined by an Administrative Law Judge (“ALJ”) in an administrative proceeding without a jury, with “conclusive” factual findings made by that ALJ. And like its predecessor bills, S. 142 includes narrow exceptions: (B) Exception. Hopefully, the cockroach is dead.
59 
Let's personalize your content